Tandem Diabetes Care announced that its t:slim mobile application is now available for download on both Android and iOS devices in Canada, effective December 18, 2025. The app pairs directly with the company’s t:slim X2 insulin pump, allowing users to view real‑time pump data, deliver boluses, and upload data to the Tandem Source cloud platform from their smartphones.
Canada had already been a market for the t:slim X2 pump since Health Canada approved the device in November 2018, but the mobile app launch completes the company’s integrated ecosystem in the country. By providing the same digital tools that U.S. patients use, Tandem expands its reach to a population of roughly 38 million people with diabetes, positioning the company to capture a larger share of the Canadian market and to support its broader strategy of global ecosystem growth.
The app requires the pump to run software version 7.8.1 or later, and while data uploads to Tandem Source are automated, they are not real‑time; users should not rely on the uploads for immediate remote patient monitoring. These technical details help ensure that Canadian users can fully leverage the app’s capabilities without unexpected limitations.
Tandem’s Q3 2025 financial results—revenue of $249 million and a gross margin increase of 3 percentage points year‑over‑year—highlight the company’s strong execution. The app expansion is part of the same growth momentum that drove the quarter’s revenue beat, as the company continues to scale its pump shipments and digital services worldwide.
John Sheridan, Tandem’s President and CEO, said the launch “furthering our commitment to expand our innovative, integrated solutions to customers worldwide.” His statement underscores the company’s focus on delivering a seamless, data‑driven experience for patients and clinicians alike.
The Canadian app launch strengthens Tandem’s competitive position by offering a complete ecosystem that rivals competitors in the insulin‑pump market. With the app now available, the company can deepen patient engagement, improve adherence, and potentially increase pump sales and subscription revenue in Canada, supporting its long‑term growth objectives.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.